Survey looks at insulin injection pain, compliance

A survey of 502 regular insulin injectors and 301 professionals who treat them found, among other things, that at least 33 percent of patients experience dread when it comes to insulin injections and 47 percent said they would be more likely to comply with their drug regimen if they had tips for relieving injection discomfort. While Novo Nordisk, Eli Lilly, Sanofi Aventis are aggressively marketing insulin analogues to increase profits, Generex Biotechnology continues to study an alternative to injectable insulin.  Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.